Trinity Celebrates Top Performers in Life Sciences with the 9th Annual Best of Benchmark Awards
On May 12, 2026, Trinity, a leading firm in strategy, insights, and analytics tailored to the life sciences industry, revealed the winners of its prestigious TGaS Advisors Best of Benchmark (BoBs) Awards. This annual event honors organizations and teams within the pharmaceutical sector that exemplify operational excellence based on comprehensive benchmarking data collected over the past two years.
Winning teams were recognized for their capacity to outperform their peers in several essential functional areas, demonstrating what the industry can achieve with the right strategies and execution. As stated by Karl Kraft, President of TGaS Advisors, these teams often operate behind the scenes, but their contributions are crucial to advancing healthcare and enhancing organizational success. By celebrating their achievements, Trinity not only acknowledges their hard work but also encourages a culture of excellence throughout the industry.
Award Winners and Their Distinctions
The 9th Annual Best of Benchmark Awards recognized several remarkable teams and their notable accomplishments:
- - Medical Operations Excellence: Boehringer Ingelheim
- - Excellence in Contract Strategy Pull-through: Genentech
- - Excellence in Pricing and Contracting Through Technological Innovations: Genentech
- - Field Reporting: Gilead
- - Excellence in Incentive Compensation Communication: Gilead
- - Digital Competency Award - Most Innovative Brand: GSK
- - Best Content Strategy: Lilly
- - Excellence in Peer Award Execution: Neurelis
- - Field Medical Affairs: Novartis
- - Master Data Management Operations: Sanofi
These winners were selected based on their performance relative to industry benchmarks, reinforcing the importance of data-driven insights in assessing success.
The Role of Trinity in Life Sciences
Trinity has been at the forefront of life sciences commercialization for over three decades, seamlessly merging human expertise with advanced technology to bring clarity and confidence across various stages of product commercialization, from pre-launch to scaling and beyond. The organization has grown significantly, expanding its footprint from its original location in Waltham, MA to numerous offices across five continents, fostering partnerships with leading pharmaceutical, biotech, and medtech companies.
As the industry continues to evolve, Trinity’s blend of deep therapeutic knowledge and innovative technology serves as a catalyst for driving operational success and delivering measurable impacts for patients. The company’s unwavering commitment to quality and client partnership sets new industry standards, proving that effective collaboration in a complex environment leads to the best outcomes in healthcare.
In conclusion, the TGaS Advisors Best of Benchmark Awards not only celebrate the accomplishments of these organizations and individuals but also reinforce the need for ongoing innovation and excellence in the life sciences sector. By shining a spotlight on these achievements, Trinity encourages other companies to strive for exceptional standards in their operations and continue to push the boundaries of what is possible in advancing healthcare solutions.
For more information on Trinity and the Best of Benchmark Awards, visit
Trinity Life Sciences.